"Mary & Elizabeth Hospital, part of UofL Health, is a 298-bed, full-service hospital. The hospital offers a full range of vascular, orthopedic, cardiac, neurological, surgical, rehabilitative and 24/7 emergency services. Mary & Elizabeth Hospital is also home to Bariatric Care, the region's only weight-loss management program utilizing the Lap-Band® System. In addition, the hospital provides the Orbera Gastric Balloon procedure. The hospital has been recognized as one of the first health care facilities in the nation to receive a Blue Distinction® Center for Bariatric Surgery. The hospital also includes a Healthy Lifestyle Center. The hospital was initially founded by the Sisters of Charity of Nazareth in 1874."

During the past decade, Saints Mary and Elizabeth Hospital conducted 130 clinical trials. In the 10-year time frame, 130 clinical trials started and 45 clinical trials were completed, i.e. on average, 34.6% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 42 clinical trials were completed. i.e. 79.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saints Mary and Elizabeth Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 75 trials, followed by "SWOG Cancer Research Network" with 30 trials sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saints Mary and Elizabeth Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 78 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Saints Mary and Elizabeth Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Invasive Breast Carcinoma" (6 trials). Many other conditions were trialed in "Saints Mary and Elizabeth Hospital" in a lesser frequency.

Most popular intervention types in "Saints Mary and Elizabeth Hospital" are "Drug" (120 trials), "Other" (94 trials), "Biological" (72 trials), "Procedure" (44 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (45 trials), "Quality-of-Life Assessment" (36 trials), "Computed Tomography" (27 trials), "Nivolumab" (26 trials) and "Biospecimen Collection" (25 trials). Other intervention names were less common.

The vast majority of trials in "Saints Mary and Elizabeth Hospital" are 127 trials for "All" genders, 24 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Saints Mary and Elizabeth Hospital". undefined are not yet recruiting, 54 are recruiting, 74 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Saints Mary and Elizabeth Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Saints Mary and Elizabeth Hospital, 3 "Phase 1" clinical trials were conducted, 79 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".